Bone Marrow Transplant Market Size, Share, Trends and Analysis

According to Stratistics MRC, the Bone Marrow Transplant market accounted for $10.58 billion in 2015 and is expected to reach $15.95 billion by 2022 growing at a CAGR of 6.0% from 2015 to 2022. Occurrence of blood cancers and increasing investment in logistic services are the key factors fueling the market growth. On the other hand, high cost of the treatment and uncertainty of reimbursement in several developing countries are the key factors hampering the market growth.
With more than 60% of the total market share in 2014, Autologous segment leads the global bone marrow transplant market due to the less considerable side effects. Allogeneic is anticipated to grow at the highest CAGR during the forecast period. Europe dominated the global market for bone marrow transplant accounting for more than 50% of the market revenue followed by North America.

Browse full report with TOC@

Some of the key players in the market include Lonza Group Ltd., Cellular Dynamics International, Merck Millipore Corporation, ABM Industries, Inc., HemaCare Corporation, ReachBio LLC, American Type Culture Collection (ATCC) Inc., Conversant Biologics, Inc., PromoCell GmbH, Sanofi-Aventis LLC, AllCells, LLC, Mesoblast Limited, STEMCELL Technologies Inc. and Lifeline Cell Technology.

Disease Indication Covered:
Blood Cancer
Myelodysplastic Syndrome
Solid Tumors
Myeloproliferative Neoplasms
Blood Disorders
Sickle cell anemia
Aplastic anemia

Transplant Type Covered:
Allogeneic Bone Marrow Transplant
Autologous Bone Marrow Transplant

End Users Covered:
Multispecialty Clinics
Ambulatory Surgery Centers

What our report offers:

- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants